上腺素作为口腔平坦菌病原体的潜在驱动因素
Yu Gyung Kim1, Kun-Hwa Kang2, Hyo-Jin Song1
1Department of Pharmacology, School of Dentistry, Kyungpook National University, Daegu, 41940, Republic of Korea.
Animal cells and systems
|November 20, 2025
概括
与压力相关的上腺素通过破坏口腔细胞和增加炎症来恶化口腔平坦 (OLP). 这项研究强调了压力激素如何影响OLP的进展,并提出了新的治疗途径.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 口腔医学是指口腔医学.
- 压力生理学 压力生理学
背景情况:
- 口腔平坦 (OLP) 是一种慢性炎症状况,涉及免疫细胞对口腔上皮细胞的攻击.
- 连接心理压力与OLP病变的确切机制尚未完全理解.
- 上腺素是一种关键的压力激素,是压力诱导的OLP恶化的潜在调解者.
研究的目的:
- 为了研究上腺素在口腔平坦的进展中的作用.
- 阐明上腺素影响口腔上皮细胞的细胞和分子机制.
主要方法:
- 在实验室中,口服角质细胞暴露在不同度的上腺素中.
- 评估细胞活力,DNA损伤和氧化应激标志物 (SOD2,SESN2).
- 分析STAT3通路激活和损伤相关分子模式 (HMGB1,细胞外ATP) 的水平.
主要成果:
- 高度的上腺素诱导了细胞毒性,降低了细胞活力,并增加了口服角质细胞中的DNA损伤.
- 上腺素降低了关键的抗氧化蛋白 (SOD2,SESN2),从而增加了氧化应激.
- 上腺素激活了STAT3通路,并增加了HMGB1和细胞外ATP的水平,这是强大的炎症调解剂.
结论:
- 压力诱导的上腺素通过促进上皮细胞损伤,氧化应激和免疫激活来促进OLP病变.
- 在OLP病变的血管化环境中,上腺素的促炎作用可能会被放大.
- 针对压力-上腺素轴是一个潜在的治疗策略来管理OLP.
相关概念视频
02:06Allergic Reactions
31.9K
Overview
31.9K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:28Adrenergic Agonists: Mixed-Action Agents
1.4K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.4K
01:27Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:30Adrenergic Agonists: Direct-Acting Agents
2.6K
Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
These agents can be classified...
2.6K